These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2431695)

  • 41. [Pharmacology of some carbamoyl derivatives of serotonin].
    Mashkovskiĭ MD; Arutiunian GS
    Farmakol Toksikol; 1971; 34(1):26-9. PubMed ID: 5563372
    [No Abstract]   [Full Text] [Related]  

  • 42. Microwave facilitation of methylatropine antagonism of central cholinomimetic drug effects.
    Quock RM; Fujimoto JM; Ishii TK; Lange DG
    Radiat Res; 1986 Mar; 105(3):328-40. PubMed ID: 3961098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Biochemical studies with oxitropium bromide. 1. Pharmacokinetics and metabolism in the rat and dog].
    Wahl D; Förster HJ; Pook KH; Richter I
    Arzneimittelforschung; 1985; 35(1A):255-65. PubMed ID: 4039166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping.
    Haddad EB; Mak JC; Barnes PJ
    Mol Pharmacol; 1994 May; 45(5):899-907. PubMed ID: 8190106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Anticholinergic action of neuroleptics and antidepressives on the guinea pig ileum. Comparison with atropine and pirenzepine].
    Alvarez Gonzalez FJ; Carvajal Garcia-Pando A; Casas Gonzalez MT; Gonzalez Martinez de Zarate JL; Velasco Martin A
    J Pharmacol; 1984; 15(2):177-84. PubMed ID: 6145814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative study on pharmacological effects of DM-phencynonate hydrochloride and its optical isomers.
    Wang LY; Zheng JQ; Wang Y; Zhong BH; Ruan JX; Liu LL
    Acta Pharmacol Sin; 2005 Oct; 26(10):1187-92. PubMed ID: 16174434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular studies on different classes of soft drugs.
    Juhász A; Bodor N
    Pharmazie; 2000 Mar; 55(3):228-38. PubMed ID: 10756546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The new anticholinergic bronchospasmolytic oxitropium bromide. Is long lasting protective effect through the night].
    Kneubühler HR; Kyd K; Benoit RC; Scherrer M
    Schweiz Med Wochenschr; 1980 May; 110(21):812-6. PubMed ID: 7394499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bronchospasmolytic effect of oxitropium bromide following powder inhalation in anaesthetized dogs.
    Traunecker W
    Arzneimittelforschung; 1988 Nov; 38(11):1623-4. PubMed ID: 3214446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cimetropium bromide, a new antispasmodic compound: pharmacology and therapeutic perspectives.
    Scarpignato C; Bianchi Porro G
    Int J Clin Pharmacol Res; 1985; 5(6):467-77. PubMed ID: 3912339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary pharmacology of a novel, smooth muscle-selective muscarinic antagonist in vivo.
    Howell RE; Laemont KD; Kovalsky MP; Lowe VC; Waid PP; Kinnier WJ; Noronha-Blob L
    J Pharmacol Exp Ther; 1994 Aug; 270(2):546-53. PubMed ID: 8071847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological study of a new competitive neuromuscular blocking steroid, pipecurium bromide.
    Kárpáti E; Biró K
    Arzneimittelforschung; 1980; 30(2a):346-57. PubMed ID: 6155921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined effect of disopyramide and bethanechol: use of bethanechol to prevent anticholinergic side effects of disopyramide without reduction of antiarrhythmic efficacy.
    Konishi T; Kadoya M; Ikeguchi S; Sakai K; Tamamura T; Kawai C
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):341-50. PubMed ID: 2476611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacodynamic profile of the new potent antibronchospastic agent 7-[(2,2-dimethyl)propyl]-1-methyl xanthine.
    Evangelista S; Ballati L; Boni P; Castellucci A; Perretti F; Tramontana M; Toja E
    Arzneimittelforschung; 1995 May; 45(5):569-75. PubMed ID: 7612055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunological release of histamine from human lung. II. Studies on acetylcholine and the anticholinergic agent ipratropium bromide.
    Morr H
    Respiration; 1979; 38(5):273-9. PubMed ID: 161410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Bronchospasmolytic effectiveness of controlled drug combinations].
    Forche G; Zenker G; Harnoncourt K
    Wien Med Wochenschr; 1986 May; 136(9):213-8. PubMed ID: 3739357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of glucagon on gastric motility examined by the acetaminophen absorption method and the endoscopic procedure.
    Kawamoto H; Yamamura H; Tatsuta M; Okuda S
    Arzneimittelforschung; 1985; 35(9):1475-7. PubMed ID: 4084348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological properties of a new antiasthmatic xanthine derivative devoid of central stimulatory activity.
    Duhault J; Boulanger M; Lonchampt M; Tisserand F; Holstorp S; Saint-Romas G; Pennel L; Regnier G
    Arzneimittelforschung; 1987 Dec; 37(12):1353-62. PubMed ID: 2835053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological properties of a new anticholinergic agent, 1, 1-dimethyl-5-methoxy-3-(dithien-2-ylmethylene) piperidinium bromide (SA-504).
    Tamaki H; Tanaka M; Murata S; Harigaya S; Kiyomoto A
    Jpn J Pharmacol; 1972 Oct; 22(5):685-99. PubMed ID: 4539786
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.